Publication | Open Access

Clinical Utility and Performance of an Ultrarapid Multiplex RNA-Based Assay for Detection of ALK, ROS1, RET, and NTRK1/2/3 Rearrangements and MET Exon 14 Skipping Alterations

Clinical UtilityNatural SciencesMedicineMolecular BiologyPathologyNucleic Acid Amplification TestAntisense TherapyMet Exon 14Gene ExpressionMolecular DiagnosticsNucleic Acid BiomarkersSkipping AlterationsNon-coding Rna